Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. (PVLA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PVLA · as of Jun 9, 2026
Key Statistics
Explore Palvella Therapeutics, Inc. Data
pvla stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 100.0%
The PVLA analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $207.67, representing +97.31% upside from the current price of $105.25.
Competitors & Peers
pvla competitorsPVLA
ABUS
EYPT
GHRS
KURA
NBTXStock Performance
Full HistoryAbout Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and…
what is palvella therapeutics, inc. · pvla stock overview · palvella therapeutics, inc. company profile · who is palvella therapeutics, inc. ceo · pvla NASDAQ · palvella therapeutics, inc. headquarters · palvella therapeutics, inc. business segments
About Stock Overview & Key Data
Palvella Therapeutics, Inc. (PVLA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 2, 2015. As of the latest trading session, PVLA stock price is $105.25, with a market capitalization of $1.2B. The stock has returned +295.23% over the past 12 months and +0.55% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Palvella Therapeutics, Inc. stock is Buy, with an average 12-month price target of $207.67. In fiscal year 2025, Palvella Therapeutics, Inc. reported revenue of — and net income of -$41.7M. For detailed data — including Palvella Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Palvella Therapeutics, Inc. (PVLA) stock price is $105.25. The stock is traded on NASDAQ under the ticker symbol PVLA. The 52-week range is $20.20 – $151.18.